Search Results - Samuel Martín‐Vílchez

Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron by Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.

An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers by Andrea Rodríguez-Lopez, Dolores Ochoa, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Eva González-Iglesias, Sergio Luquero-Bueno, Manuel Román, Gina Mejía-Abril, Francisco Abad-Santos

Connect to this object online.

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials by Eva González-Iglesias, Dolores Ochoa, Manuel Román, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Alejandro De Miguel, Pablo Zubiaur, Andrea Rodríguez-Lopez, Francisco Abad-Santos, Francisco Abad-Santos, Jesús Novalbos

Connect to this object online.

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin by Gonzalo Villapalos-García, Pablo Zubiaur, Marcos Navares-Gómez, Miriam Saiz-Rodríguez, Gina Mejía-Abril, Samuel Martín-Vílchez, Manuel Román, Manuel Román, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine by Sofía Calleja, Pablo Zubiaur, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Gina Mejia-Abril, Paula Soria-Chacartegui, Marcos Navares-Gómez, Alejandro de Miguel, Manuel Román, Samuel Martín-Vílchez, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety by Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos

Connect to this object online.

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride by Diana María Campodónico, Pablo Zubiaur, Paula Soria‐Chacartegui, Ana Casajús, Gonzalo Villapalos‐García, Marcos Navares‐Gómez, Antía Gómez‐Fernández, Raúl Parra‐Garcés, Gina Mejía‐Abril, Manuel Román, Samuel Martín‐Vílchez, Dolores Ochoa, Francisco Abad‐Santos

Connect to this object online.

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers by Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, Gina Mejía-Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Bernd Jilma, María A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Víctor M. González, Ignacio Lizasoain, Francisco Abad-Santos

Connect to this object online.

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline by Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.